127

Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364, 524–534; Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013). Impact of direct-to-consumer genomic testing at long term follow-up. Journal of Medical Genetics, 50, 393–400; Egglestone, C., Morris, A., & O’Brien, A. (2013). Effect of direct-to-consumer genetic tests on health behavior and anxiety: A survey of consumers and potential consumers. Journal of Genetic Counselling, 22, 565–575; Gordon, E. S., et al. (2012). «It’s not like judgment day»: Public understanding and reactions to personalized genomic risk information. Journal of Genetic Counselling, 21, 423–432; Hershka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10, 19–32.